Other
Menopausal Women
0
Pipeline Programs↗
8
Active Trials↗
18
Companies Involved↗
Menopausal Women is an early-stage landscape with 0 programs across 18 companies. The most active players are Sprout Pharmaceuticals, Inc, Novartis, Eli Lilly.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
87
clinical trials
Completed59 · 68%
Unknown status14 · 16%
Terminated5 · 6%
Not yet recruiting4 · 5%
Active, not recruiting2 · 2%
Recruiting2 · 2%
Other1 · 1%
Clinical Trials
Trial Activity
87 trials
External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia
Recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 3·NCT06966245·190 enrolled
External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia
Not yet recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 3·NCT06404775·456 enrolled
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Completed·—·Phase 3·NCT00331123·562 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)